SG Americas Securities’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Sell
15,479
-152
-1% -$1.95K ﹤0.01% 2594
2025
Q4
$162K Buy
15,631
+5,165
+49% +$46.6K ﹤0.01% 3018
2025
Q3
$62K Buy
+10,466
New +$76.6K ﹤0.01% 3166
2025
Q2
Sell
-16,636
Closed -$126K 3017
2025
Q1
$126K Sell
16,636
-6,565
-28% -$63K ﹤0.01% 2876
2024
Q4
$283K Buy
23,201
+8,144
+54% +$117K ﹤0.01% 1843
2024
Q3
$252K Sell
15,057
-70,115
-82% -$1.24M ﹤0.01% 2294
2024
Q2
$1.49M Buy
85,172
+75,236
+757% +$1.6M 0.01% 1113
2024
Q1
$169K Sell
9,936
-4,513
-31% -$69.7K ﹤0.01% 2099
2023
Q4
$147K Buy
14,449
+1,587
+12% +$14.1K ﹤0.01% 2433
2023
Q3
$116K Buy
+12,862
New +$134K ﹤0.01% 2693
2023
Q2
Sell
-11,066
Closed -$113K 2407
2023
Q1
$113K Sell
11,066
-1,071
-9% -$11.8K ﹤0.01% 2831
2022
Q4
$128K Buy
12,137
+949
+8% +$11.5K ﹤0.01% 2543
2022
Q3
$143K Sell
11,188
-1,420
-11% -$19.1K ﹤0.01% 2580
2022
Q2
$162K Buy
+12,608
New +$143K ﹤0.01% 2812
2022
Q1
Sell
-10,916
Closed -$168K 3018
2021
Q4
$168K Sell
10,916
-4,947
-31% -$98.7K ﹤0.01% 2758
2021
Q3
$358K Buy
+15,863
New +$424K ﹤0.01% 2787

Other funds holding CGEM